Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

pertuzumab

- PMLiVE

UK government launches Healthwatch England to champion patient voices

Will support public opinion in health and social care

Roche - Basel

Roche’s T-DM1 activity in breast cancer “outstanding”

Improves survival by six months compared to GSK’s Tykerb/Tyverb

A new dogma in HTA assessment

New communication routes to HTA agencies are needed to ensure that these organisations can advise on clinical trial design

- PMLiVE

The bigger picture in medicine value

By focusing on cost are we obscuring the true value of medicines?

- PMLiVE

Roche plans translational research centre in New York

Follows plan to close New Jersey headquarters

- PMLiVE

UK NHS reforms create £20bn opportunity for private sector

Report from Catalyst says NHS reforms pave way for healthcare companies

- PMLiVE

UK hospitals cannot cope with demand says RCP

Report claims acute care on “brink of collapse”

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

- PMLiVE

Roche loses Indian Tarceva patent battle with Cipla

As Novartis' Glivec patent law challenge begins again

- PMLiVE

GSK persuades NICE to reconsider negative Benlysta decision

Decision on lupus drug referred to expert committee following appeal

- PMLiVE

NHS social network How Are You? launches UK’s first health app store

A partnership with Cambridge Healthcare, the network's store offers easy access to health apps

- PMLiVE

Scottish cabinet reshuffle sees Alex Neil made health secretary

Moves from infrastructure, investment and cities to take over from Nicola Sturgeon

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links